B

Bio-Gene Technology Ltd
ASX:BGT

Watchlist Manager
Bio-Gene Technology Ltd
ASX:BGT
Watchlist
Price: 0.03 AUD Market Closed
Market Cap: AU$9.2m

Operating Margin

-631.3%
Current
Declining
by 179.4%
vs 3-y average of -451.9%

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
-631.3%
=
Operating Income
AU$-2.7m
/
Revenue
AU$425.1k

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
-631.3%
=
Operating Income
AU$-2.7m
/
Revenue
AU$425.1k

Peer Comparison

Country Company Market Cap Operating
Margin
AU
Bio-Gene Technology Ltd
ASX:BGT
9.2m AUD
Loading...
US
Corteva Inc
NYSE:CTVA
48.9B USD
Loading...
CA
Nutrien Ltd
TSX:NTR
46.7B CAD
Loading...
CN
Qinghai Salt Lake Industry Co Ltd
SZSE:000792
190.1B CNY
Loading...
CL
Sociedad Quimica y Minera de Chile SA
NYSE:SQM
24.1B USD
Loading...
CN
Zangge Mining Co Ltd
SZSE:000408
141.6B CNY
Loading...
US
CF Industries Holdings Inc
NYSE:CF
14.4B USD
Loading...
SA
SABIC Agri-Nutrients Company SJSC
SAU:2020
53.8B SAR
Loading...
CN
Shandong Hualu-Hengsheng Chemical Co Ltd
SSE:600426
80.7B CNY
Loading...
NO
Yara International ASA
OSE:YAR
110.7B NOK
Loading...
RU
PhosAgro PAO
MOEX:PHOR
831.9B RUB
Loading...

Market Distribution

Lower than 71% of companies in Australia
Percentile
29th
Based on 3 951 companies
29th percentile
-631.3%
Low
-14 949 200% — -526.4%
Typical Range
-526.4% — 6.1%
High
6.1% — 145 596.9%
Distribution Statistics
Australia
Min -14 949 200%
30th Percentile -526.4%
Median -25.2%
70th Percentile 6.1%
Max 145 596.9%

Bio-Gene Technology Ltd
Glance View

Market Cap
9.2m AUD
Industry
Chemicals

Bio-Gene Technology Ltd. is a development company enabling the next generation of novel insecticides, addressing the problems of insecticide resistance and toxicity. The company is headquartered in Melbourne, Victoria. The company went IPO on 2017-11-29. The Company’s principal activity is to develop and commercialize insecticide products. The company is focused on enabling novel insecticides to address the global problem of insecticide resistance and toxicity. Its novel platform technology is based on naturally occurring beta-triketones. The Company’s lead beta-triketone insecticide products include Flavocide and Qcide. Flavocide is a synthetically produced nature-identical compound. Testing of Flavocide has been undertaken and continues to be performed by both government research laboratories as well as by commercial collaborators. Qcide natural oil with high levels of tasmanone. The oil is extracted from the leaves of the Gympie Messmate, by utilizing a steam distillation process.

BGT Intrinsic Value
0.002 AUD
Overvaluation 92%
Intrinsic Value
Price
B
What is Operating Margin?
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
How is Operating Margin calculated?

Operating Margin is calculated by dividing the Operating Income by the Revenue.

Operating Margin
-631.3%
=
Operating Income
AU$-2.7m
/
Revenue
AU$425.1k
What is Bio-Gene Technology Ltd's current Operating Margin?

The current Operating Margin for Bio-Gene Technology Ltd is -631.3%, which is below its 3-year median of -451.9%.

How has Operating Margin changed over time?

Over the last 3 years, Bio-Gene Technology Ltd’s Operating Margin has decreased from -313.2% to -631.3%. During this period, it reached a low of -631.3% on Jul 30, 2025 and a high of -313.2% on May 30, 2022.

Back to Top